S

Stille AB
STO:STIL

Watchlist Manager
Stille AB
STO:STIL
Watchlist
Price: 230 SEK 0.44% Market Closed
Market Cap: kr2.1B

STIL's latest stock split occurred on Jun 24, 2008

The company executed a 1-for-100 stock split, meaning that for every 100 shares held, investors received 1 new share.

The adjusted shares began trading on Jun 24, 2008. This was STIL's 2nd stock split, following the previous one in Jul 25, 2007.

Last Splits:
Jun 24, 2008
1-for-100
Jul 25, 2007
52-for-49
Pre-Split Price
N/A
Post-Split Price
6.5877
Before
After
Last Splits:
Jun 24, 2008
1-for-100
Jul 25, 2007
52-for-49

Stille AB
Stock Splits History

STIL Stock Splits Timeline
Jun 24, 2008
Jun 24, 2008
Split 1-for-100
/0.01
Pre-Split Price
N/A
Post-Split Price
6.5877
Before
After
Jul 25, 2007
Jul 25, 2007
Split 52-for-49
x1.0612244897959
Pre-Split Price
N/A
Post-Split Price
6.5877
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 24, 2026
Cue Biopharma Inc
NASDAQ:CUE
1-for-30
/30
0.5542 16.626 USD 17.695 17.695 USD
Apr 24, 2026
Medical Data Vision Co Ltd
TSE:3902
2-for-7253607
/3626803.5
1684 1684 JPY N/A
Apr 24, 2026
E
ESGL Holdings Ltd
NASDAQ:ESGL
1-for-3
/3
2.35 7.05 USD 2.93 2.93 USD
Apr 24, 2026
Metro Mining Ltd
ASX:MMI
1-for-20
/20
0.067 1.34 AUD 1.3 1.3 AUD
Apr 24, 2026
L
La Comer SAB de CV
OTC:LCMRF
115-for-114
x1.0087719298246
2.4715 2.4341 USD 2.45 2.45 USD
Load More

Stille AB
Glance View

Market Cap
2.1B SEK
Industry
Health Care

Stille AB engages in the development and sale of medical equipment. The company is headquartered in Torshaella, Sodermanlands. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.

STIL Intrinsic Value
196.92 SEK
Overvaluation 14%
Intrinsic Value
Price kr230
S
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett